Medical Weight Loss for Rialto, California Residents
Rialto, California residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Rialto through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Rialto Residents Choose New Hope Weight Loss
Rialto patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across California and beyond since 2020.
Rialto is served through telehealth from our Costa Mesa, California clinic. The full physician-supervised GLP-1 program runs by secure video, with compounded medication shipped to your Rialto address.
Rialto is served entirely by telehealth, so there is no local office to visit and no waiting room. We care for patients throughout downtown Rialto and the greater San Bernardino County area. Spanish-speaking Rialto patients complete the entire program, intake, consultation, and follow-up, in Spanish with our bilingual team.
Our telehealth model serves Rialto and communities across California with the same flat pricing and the same supervising physician. Compounded medication arrives in discreet, cold-pack packaging at your Rialto address, usually within days.
GLP-1 Weight Loss Programs Available
Compounded semaglutide, from $166/mo (90-day program $499)
The 90-day Metabolic Reset is our most-chosen plan. Semaglutide shares its active ingredient with Wegovy® and Ozempic®; in trials of the branded drug, patients lost an average of 15-17% of body weight under physician supervision.
Compounded tirzepatide, from $233/mo
Tirzepatide's dual GLP-1/GIP action reached up to 22.5% body-weight loss in trials of the branded medication, the advanced option for Rialto patients.
The physician review is a flat $119, with medication billed separately; HSA, FSA, Klarna, and Affirm are accepted.
How Telehealth Works for Rialto
Step 1: Complete the 2-minute quiz or the medical intake form online.
Step 2: Dr. Sharma reviews your history by secure video, typically within 48 hours.
Step 3: If you are a candidate and telehealth-eligible, the state-licensed 503(a) pharmacy ships your compounded medication to your Rialto address in cold-pack packaging. Follow-ups and dose adjustments also happen by video, no travel required.
Frequently Asked Questions, Rialto
How do I get treatment from Rialto?
As a Rialto, California patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Rialto?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Rialto in cold-pack packaging, no lines and no drive.
How much does it cost for Rialto patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Rialto do you serve?
We serve patients from across Rialto by telehealth, including downtown Rialto and the greater San Bernardino County area.
Are there hidden fees for Rialto patients?
No. Rialto patients pay the same flat, stated pricing: a $119 physician visit, then compounded semaglutide from $166/month or tirzepatide from $233/month with medication billed separately. There is no membership lock-in and no distance surcharge.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Rialto, California by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.